Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunctionYingzhi Bi, John E. Macor, Patrick Stoy et al.|Bioorganic & Medicinal Chemistry Letters|2004Cited by 49
Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors: Potential Agents for Treatment of Erectile DysfunctionGuixue Yu, John E. Macor, Diane E. Normandin et al.|Journal of Medicinal Chemistry|2003Cited by 38
The discovery of novel, potent and selective PDE5 inhibitorsYingzhi Bi, John E. Macor, Patrick Stoy et al.|Bioorganic & Medicinal Chemistry Letters|2001Cited by 30
Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-D-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J. Bristow, Michael Sinz, Jyoti Gulia et al.|Journal of Pharmacology and Experimental Therapeutics|2017Cited by 17
Design and Synthesis of 4-Heteroaryl 1,2,3,4-Tetrahydroisoquinolines as Triple Reuptake InhibitorsShuang Liu, John E. Macor, Congxiang Zha et al.|ACS Medicinal Chemistry Letters|2014Cited by 17